This repeated cross-sectional study including 69.2 million obesity management drug dispensed prescriptions revealed an increase from 0.76 million in July 2017 to 1.5 million in February 2024, with an ...

Websites that sell compounded glucagon-like peptide-1 receptor agonists often partially inform or misinform consumers.

Tirzepatide Peptide Tirzepatide is another synthetic peptide engineered to target metabolic pathways. Research indicates that its unique design may allow it to act as an agonist for GLP-1 and GIP ...

Semaglutide (brand name Wegovy), liraglutide (Saxenda), and tirzepatide (Zepbound) are all glucagon-like peptide-1 (GLP-1 ...

Clinics in Columbus, Cleveland, Dayton, and Cincinnati have lost their licenses to distribute dangerous drugs after the Ohio ...

Leerink Partners analyst David Risinger maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) on January 24 and set a price ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

Tirzepatide, a dual agonist of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors, represents a novel therapeutic option for both glycemic control and ...

A team of scientists has developed a groundbreaking approach using specially designed peptides to improve drug formulations.

Websites that sell compounded glucagon-like peptide-1 receptor agonists (GLP-1 RAs) often partially inform or misinform ...